secwatch.observer — SEC 8-K summary
======================================

Issuer:     PMGC Holdings Inc. (ELAB)
CIK:        0001840563
Form:       8-K
Filed at:   2026-02-11T23:59:59+00:00
Accession:  0001213900-26-015003
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PMGC subsidiary NorthStrive signs exclusive license for EL-22/EL-32 in animal health
--------------------------------------------------------------------------------

- Definitive license with Modulant Biosciences for myostatin-engineered probiotic EL-22 and EL-32.
- Modulant gets exclusive, royalty-bearing, sublicensable license for non-human animal health worldwide except Korea.
- Modulant pays value (undisclosed) and handles development, manufacturing, regulatory, commercialization.
- License excludes human pharmaceutical applications; shared ownership of improvements.
- Follows binding term sheet from May 2025; no assurance of commercial success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840563/000121390026015003/0001213900-26-015003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840563/000121390026015003/ea0276475-8k_pmgc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-015003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer